SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001999371-24-005989
Filing Date
2024-05-13
Accepted
2024-05-13 16:51:45
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_033124.htm   iXBRL 10-Q 1078030
2 CHIEF EXECUTIVE OFFICER'S CERTIFICATE PURSUANT TO SECTION 302 ex31-01.htm EX-31.01 10497
3 CHIEF FINANCIAL OFFICER'S CERTIFICATE PURSUANT TO SECTION 302 ex31-02.htm EX-31.02 10657
4 CHIEF EXECUTIVE OFFICER'S AND CHIEF EXECUTIVE OFFICER'S CERTIFICATE PURSUANT TO ex32-01.htm EX-32.01 5611
  Complete submission text file 0001999371-24-005989.txt   6836843

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE tnxp-20240331.xsd EX-101.SCH 63994
6 XBRL CALCULATION FILE tnxp-20240331_cal.xml EX-101.CAL 79932
7 XBRL DEFINITION FILE tnxp-20240331_def.xml EX-101.DEF 263516
8 XBRL LABEL FILE tnxp-20240331_lab.xml EX-101.LAB 461082
9 XBRL PRESENTATION FILE tnxp-20240331_pre.xml EX-101.PRE 378673
95 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10q_033124_htm.xml XML 961094
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 24939910
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)